Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.fda.gov/news-events/press-announcements/fda-approves-first-orally-administered-fecal-microbiota-product-prevention-recurrence-clostridioides
0
0
FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection - FDA.gov
4/26/23 at 9:53pm
Organization
FDA.gov
Author
Office of the Commissioner
Details
37 words
Summarize
Infectious Diseases
Business & Industrial
FDA Approves First Orally Administered Fecal Microbiota Product
FDA
Prevention of Recurrence of Clostridioides difficile Infection - FDA.gov
Clostridioides
microbiota product
microbiota product
FDA approves first orally administered fecal microbiota product for prevention of recurrence of Clostridioides difficile infection in adults
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...